Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | CDC14B | O60729 | 3/20 | 0.33 |
| ▸ | CDC14A | Q9UNH5 | 3/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | TNKS | O95271 | 1/20 | 0.31 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21785833 | 0.91 | AHR (0.38) | CDC14BCDC14AAHRTNKSALK | |
| SCHEMBL20927650 | 0.89 | MAOB (0.35) | GPR84CDC14BCDC14AAHRTNKS | |
| SCHEMBL20927646 | 0.85 | CDC14B (0.35) | CDC14BCDC14AAHRTNKSALK | |
| SCHEMBL20927694 | 0.85 | GPR84 (0.33) | GPR84CDC14BCDC14AALK | |
| SCHEMBL20927728 | 0.85 | GPR84 (0.33) | GPR84AHRTNKSALKCA1 | |
| SCHEMBL20927663 | 0.85 | PDK2 (0.34) | CDC14BCDC14AAHRTNKSALK | |
| SCHEMBL21785826 | 0.85 | AHR (0.35) | CDC14BCDC14AAHRTNKSALK | |
| SCHEMBL20927710 | 0.84 | CDC14B (0.34) | GPR84CDC14BCDC14AALK | |
| SCHEMBL20927699 | 0.83 | ALDH1A1 (0.35) | GPR84CDC14BCDC14ATNKSALDH1A1 | |
| SCHEMBL20927668 | 0.83 | AHR (0.37) | CDC14BCDC14AAHRTNKSCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11578063-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2023-02-14 | — | — | US | disclosed |
| US-20200277284-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-09-03 | — | — | US | disclosed |
| WO-2019076789-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-04-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200277284-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | L1CAM, EFNA1, EPCAM | GPR84 4089/4885CDC14B 4597/4885CDC14A 4518/4885 |
| US-11578063-B2 | Materials for organic electroluminescent devices | GPX1, EPCAM, EFNA1 | GPR84 4056/4885CDC14B 4688/4885CDC14A 4632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.